Activating Mutations of c-Kit at Codon 816 Confer Drug Resistance in Human Leukemia Cells

References

• Yarden Y., Kuang W. J., Yang-Feng T., Coussens L., Munemitsu S., Dull T. J., Chen E., Schlessinger J., Francke U., Ullrich A. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987; 6: 3341–3351
   PubMed Web of Science ®Google Scholar
• Qiu F. H., Ray P., Brown K., Barker P. E., Jhanwar S., Ruddle F. H., Besmer P. Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J 1988; 7: 1003–1011
   PubMed Web of Science ®Google Scholar
• Williams D. E., Eisenman J., Baird A., Rauch C., Van Ness K., March C. J., Park L. S., Martin U., Mochizuki D. Y., Boswell H. S., et al. Identification of a ligand for the c-kit proto-oncogene. Cell 1990; 63: 167–174
   PubMed Web of Science ®Google Scholar
• Flanagan J. G., Leder P. The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell 1990; 63: 185–194
   PubMed Web of Science ®Google Scholar
• Zsebo K. M., Williams D. A., Geissler E. N., Broudy V. C., Martin F. H., Atkins H. L., Hsu R. Y., Birkett N. C., Okino K. H., Murdock D. C., et al. Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990; 63: 213–224
   PubMed Web of Science ®Google Scholar
• Huang E., Nocka K., Beier D. R., Chu T. Y., Buck J., Lahm H. W., Wellner D., Leder P., Besmer P. The hematopoietic growth factor KL is encoded by the S1 locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 1990; 63: 225–233
   PubMed Web of Science ®Google Scholar
• Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203–212
   PubMed Web of Science ®Google Scholar
• Linnekin D. Early signaling pathways activated by c-Kit in hematopoietic cells. Int J Biochem Cell Biol 1999; 31: 1053–1074
   PubMed Web of Science ®Google Scholar
• Fleischman R. A. From white spots to stem cells: the role of the Kit receptor in mammalian development. Trends Genet 1993; 9: 285–290
   PubMed Web of Science ®Google Scholar
• Ashman L. K. The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol 1999; 31: 1037–1051
   PubMed Web of Science ®Google Scholar
• Blume-Jensen P., Jiang G., Hyman R., Lee K. F., O'Gorman S., Hunter T. Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility. Nat Genet 2000; 24: 157–162
   PubMed Web of Science ®Google Scholar
• Ikeda H., Kanakura Y., Tamaki T., Kuriu A., Kitayama H., Ishikawa J., Kanayama Y., Yonezawa T., Tarui S., Griffin J. D. Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood 1991; 78: 2962–2968
   PubMed Web of Science ®Google Scholar
• Furitsu T., Tsujimura T., Tono T., Dceda H., Kitayama H., Koshimizu U., Sugahara H., Butterfield J. H., Ashman L. K., Kanayama Y., et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993; 92: 1736–1744
   PubMed Web of Science ®Google Scholar
• Tsujimura T., Furitsu T., Morimoto M., Isozaki K., Nomura S., Matsuzawa Y., Kitamura Y., Kanakura Y. Lig-and-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 1994; 83: 2619–2626
   PubMed Web of Science ®Google Scholar
• Piao X., Bernstein A. A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells. Blood 1996; 87: 3117–3123
   PubMed Web of Science ®Google Scholar
• Leslie N. R., O'Prey J., Bartholomew C., Harrison P. R. An activating mutation in the kit receptor abolishes the stroma requirement for growth of ELM erythroleukemia cells, but does not prevent their differentiation in response to erythropoietin. Blood 1998; 92: 4798–4807
   PubMed Web of Science ®Google Scholar
• Ashman L. K., Ferrao P., Cole S. R., Cambareri A. C. Effects of mutant c-Kit in early myeloid cells. Leuk Lymphoma 1999; 34: 451–461
   PubMed Web of Science ®Google Scholar
• Beghini A., Peterlongo P., Ripamonti C. B., Larizza L., Cairoli R., Morra E., Mecucci C. c-kit mutations in core binding factor leukemias. Blood 2000; 95: 726–727
   PubMed Web of Science ®Google Scholar
• Kitayama H., Kanakura Y., Furitsu T., Tsujimura T., Oritani K., Ikeda H., Sugahara H., Mitsui H., Kanayama Y., Kitamura Y., et al. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 1995; 85: 790–798
   PubMed Web of Science ®Google Scholar
• Hashimoto K., Tsujimura T., Moriyama Y., Yamatodani A., Kimura M., Tohya K., Morimoto M., Kitayama H., Kanakura Y., Kitamura Y. Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell line. Am J Pathol 1996; 148: 189–200
   PubMed Web of Science ®Google Scholar
• Nagata H., Worobec A. S., Oh C. K., Chowdhury B. A., Tannenbaum S., Suzuki Y., Metcalfe D. D. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995; 92: 10560–10564
   PubMed Web of Science ®Google Scholar
• Longley B. J., Jr, Metcalfe D. D., Tharp M., Wang X., Tyrrell L., Lu S. Z., Heitjan D., Ma Y. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 1999; 96: 1609–1614
   PubMed Web of Science ®Google Scholar
• Tian Q., Frierson H. F., Jr, Krystal G. W., Moskaluk C. A. Activating c-kit gene mutations in human germ cell tumors. Am J Pathol 1999; 154: 1643–1647
   PubMed Web of Science ®Google Scholar
• Reith A. D., Ellis C., Lyman S. D., Anderson D. M., Williams D. E., Bernstein A., Pawson T. Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase. EMBO J 1991; 10: 2451–2459
   PubMed Web of Science ®Google Scholar
• Crosier P. S., Ricciardi S. T., Hall L. R., Vitas M. R., Clark S. C., Crosier K. E. Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia. Blood 1993; 82: 1151–1158
   PubMed Web of Science ®Google Scholar
• Ning Z. Q., Murphy J. J. Calcium ionophore-induced apoptosis of human B cells is preceded by the induced expression of early response genes. Eur J Immunol 1993; 23: 3369–3372
   PubMed Web of Science ®Google Scholar
• Dive C., Gregory C. D., Phipps D. J., Evans D. L., Milner A. E., Wyllie A. H. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta 1992; 1133: 275–285
   PubMed Web of Science ®Google Scholar
• Hirota S., Isozaki K., Moriyama Y., Hashimoto K., Nishida T., Ishiguro S., Kawano K., Hanada M., Kurata A., Takeda M., Muhammad Tunio G., Matsuzawa Y., Kanakura Y., Shinomura Y., Kitamura Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577–580
   PubMed Web of Science ®Google Scholar
• Yokota S., Kiyoi H., Nakao M., Iwai T., Misawa S., Okuda T., Sonoda Y., Abe T., Kahsima K., Matsuo Y., Naoe T. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines. Leukemia 1997; 11: 1605–1609
   PubMed Web of Science ®Google Scholar
• Kiyoi H., Naoe T., Nakano Y., Yokota S., Minami S., Miyawaki S., Asou N., Kuriyama K., Jinnai I., Shimazaki C., Akiyama H., Saito K., Oh H., Motoji T., Omoto E., Saito H., Ohno R., Ueda R. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 1999; 93: 3074–3080
   PubMed Web of Science ®Google Scholar
• Piao X., Paulson R., van der Geer P., Pawson T., Bernstein A. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. Proc Natl Acad Sci USA 1996; 93: 14665–14669
   PubMed Web of Science ®Google Scholar